Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk ...

Medibyt's CPETWise automated platform aims to cut cardiopulmonary exercise testing interpretation time in half and ...

A national study reveals fewer pediatricians report emotional exhaustion, though overall burnout prevalence in healthcare ...

Targeting key cellular proteins may provide new opportunities to diagnose, prevent, and treat pulmonary arterial hypertension ...

AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, plus infant COVID-19 ...

Draeger issued a letter to affected customers recommending certain VentStar Resus Neo hoses be removed from where they are ...

IDSA recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines immunocompromised patients.

Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).

A clinical trial will evaluate a weekly dry powder nasal spray's ability to boost natural defenses and prevent asthma infections.

The American Lung Association provides personalized guidance from RTs and nurses to help pulmonary fibrosis patients manage lung disease.

GE HealthCare issued updated use instructions for certain patient monitoring devices, according to an FDA alert.

FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.